Evaluation of a gadolinium-based nanoparticle (AGuIX) for contrast enhanced MRI of the liver in a rat model of hepatic colorectal cancer metastases at 9.4 tesla
Rofo., 2015, 187, 1108-1115.
P. Fries, D. Morr, A. Müller, F. Lux, O. Tillement, A. Massmann, R. Seidel, T. Schäfer, M. D. Mengel, G. Schneider, A. Bücker
Gadolinium nanoparticles and contrast agent as radiation sensitizers
Phys. Med. Biol., 2015, 60, 4449-4464.
F. Taupin, M. Flaender, R. Delorme, T. Brochard, J.F. Mayol, J. Arnaud, P. Perriat, L. Sancey, F. Lux, R. F. Barth, M. Carrière, J. L. Ravanat, H. Elleaume
Orotracheal administration of contrast agents : a new protocol for brain tumor targeting
NMR Biomed., 2015, 28, 738-746.
A. Bianchi, D. Moncelet, F. Lux, M. Plissonneau, S. Rizzitelli, E. J. Ribot, N. Tassali, V. Bouchaud, O. Tillement, P. Voisin, Y. Crémillieux
Nebulized gadolinium-based nanoparticles : a theranostic approach for lung tumor imaging and radiosensitization
Small, 2015, 11, 215-221.
S. Dufort, A. Bianchi, M. Henry, F. Lux, G. Le Duc, V. Josserand, C. Louis, P. Perriat, Y. Crémillieux, O. Tillement, J.-L. Coll
Combining ultrasmall gadolinium-based nanoparticles with photon irradiation overcomes radioresistance of head and neck squamous cell carcinoma
Nanomedicine:NBM, 2015, 11, 247-257.
I. Miladi, M. –T. Aloy, E. Armandy, P. Mowat, D. Kryza, N. Magné, O. Tillement, F. Lux, C. Billotey, M. Janier, C. Rodriguez-Lafrasse